MSK Experts Report New Findings about Multiple Myeloma at the 2019 ASH Meeting
Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.
Related Articles
MSK Research Highlights June 18, 2025
New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes;…
Memorial Sloan Kettering Cancer Center at ASCO 2025
Physicians and scientists from MSK are meeting with members of the global cancer research community at ASCO from May 30 – June 3. Follow along…
Memorial Sloan Kettering Cancer Center at ASCO 2025
Physicians and scientists from MSK are meeting with members of the global cancer research community at ASCO from May 30 – June 3. Follow along…
Memorial Sloan Kettering Cancer Center at ASCO 2025
Physicians and scientists from MSK are meeting with members of the global cancer research community at ASCO from May 30 – June 3. Follow along…
Memorial Sloan Kettering Cancer Center at ASCO 2025
Physicians and scientists from MSK are meeting with members of the global cancer research community at ASCO from May 30 – June 3. Follow along…
Memorial Sloan Kettering Cancer Center at ASCO 2025
Physicians and scientists from MSK are meeting with members of the global cancer research community at ASCO from May 30 – June 3. Follow along…
Magnet® Recognition
The Magnet Recognition Program recognizes healthcare organizations that set the gold standard for nursing excellence in every category, from patient care to leadership and scientific…
APOBEC3 mutagenesis drives therapy resistance in breast cancer
Nature Genetics – Analysis of a large cohort of metastatic breast cancer samples shows that APOBEC mutational signatures are enriched in post-treatment samples. APOBEC activity…
Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study
Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch repair-deficient (dMMR) solid tumors across multiple types. Most patients…
Using Only Immunotherapy Successfully Treats Several Cancers With MMRd
Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo…